• Company
• JW Pharma develops new drugs with Merck Life Science
• by Lee, Seok-Jun Feb 1, 2023 05:55am

• Policy
• South Korea will maintain its EU whitelist
• by Lee, Hye-Kyung Feb 1, 2023 05:54am

• Company
• Clotinab, exclusive in the bio-anti-hemolysis market
• by Nho, Byung Chul Feb 1, 2023 05:54am

• Company
• Imfinzi expands biliary cancer indication
• by Feb 1, 2023 05:54am

• Opinion
• [Reporter’s View] CDDC continues to raise controversy
• by Eo, Yun-Ho Feb 1, 2023 05:54am

• Company
• Sales of statin-ezetimibe combo rise threefold in 3 yrs
• by Chon, Seung-Hyun Feb 1, 2023 05:54am

• Policy
• KMA·MOHW discusses essential healthcare at 1st meeting
• by Lee, Jeong-Hwan Jan 31, 2023 05:59am

• Company
• Merck makes large investments in Korea’s science tech
• by Jan 31, 2023 05:59am

• Company
• MSD Korea to replace its leader for the first time in 2 yrs
• by Jan 31, 2023 05:59am

• Policy
• The legislation of cold chain improvement plan is announced
• by Lee, Hye-Kyung Jan 30, 2023 05:55am